Risk factors for end-stage kidney disease after pediatric liver transplantation

American Journal of Transplantation

Volumn 12, Issue 12, 2012, Pages 3398-3405

  Ruebner, R L ^a   Reese, P P ^b,c   Denburg, M R ^a,b   Rand, E B ^a   Abt, P L ^b   Furth, S L ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

End stage renal disease; liver transplantation; mortality; pediatric liver transplant; Scientific Registry of Transplant Recipients

Indexed keywords

AGE; ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RACE; RETRANSPLANTATION; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

EID: 84870542050     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04270.x     Document Type: Article

References (43)

1. Ojo AO, Held PJ, Port FK, et al,. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
2. Gonwa TA, Mai ML, Melton LB, et al,. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment. Transplantation 2001; 72: 1934-1939.
3. Sharma P, Schaubel DE, Guidinger MK, Goodrich NP, Ojo AO, Merion RM,. Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant 2011; 11: 2372-2378.
4. Baran DA, Galin ID, Gass AL,. Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: Risk factors and strategies for prevention and treatment. Am J Cardiovasc Drugs 2004; 4: 21-29.
5. Naesens M, Kuypers DR, Sarwal M,. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481-508.
6. Pillebout E, Nochy D, Hill G, et al,. Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 2005; 5: 1120-1129.
7. Tonshoff B, Hocker B,. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Pediatr Transplant 2006; 10: 721-729.
8. Campbell MS, Kotlyar DS, Brensinger CM, et al,. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transplant 2005; 11: 1048-1055.
9. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N,. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: Where will MELD lead us Am J Transplant 2006; 6: 2651-2659.
10. Harambat J, Ranchin B, Dubourg L, et al,. Renal function in pediatric liver transplantation: A long-term follow-up study. Transplantation 2008; 86: 1028-1034.
11. McLin VA, Anand R, Daniels SR, Yin W, Alonso EM,. Blood pressure elevation in long-term survivors of pediatric liver transplantation. Am J Transplant 2012; 12: 183-190.
12. Nair S, Verma S, Thuluvath PJ,. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179-1185.
13. O'Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ,. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant 2006; 21: 2630-2636.
14. Pawarode A, Fine DM, Thuluvath PJ,. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transplant 2003; 9: 741-747.
15. Velidedeoglu E, Bloom RD, Crawford MD, et al,. Early kidney dysfunction postliver transplantation predicts late chronic kidney disease. Transplantation 2004; 77: 553-556.
16. Gonwa TA,. Hypertension and renal dysfunction in long-term liver transplant recipients. Liver Transplant 2001; 7 (11 Suppl 1): S22-S26.
17. Schwartz GJ, Munoz A, Schneider MF, et al,. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637.
18. Cole TJ,. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44: 45-60.
19. Ogden CL, Kuczmarski RJ, Flegal KM, et al,. Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 45-60.
20. Arora-Gupta N, Davies P, McKiernan P, Kelly DA,. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplant 2004; 8: 145-150.
21. Mention K, Lahoche-Manucci A, Bonnevalle M, et al,. Renal function outcome in pediatric liver transplant recipients. Pediatr Transplant 2005; 9: 201-207.
22. Campbell KM, Yazigi N, Ryckman FC, et al,. High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr 2006; 148: 475-480.
23. Kivela JM, Raisanen-Sokolowski A, Pakarinen MP, et al,. Long-term renal function in children after liver transplantation. Transplantation 2011; 91: 115-120.
24. Campbell K, Ng V, Martin S, et al,. Glomerular filtration rate following pediatric liver transplantation-The SPLIT experience. Am J Transplant 2010; 10: 2673-2682.
25. Anastaze Stelle K, Belli DC, Parvex P, et al,. Glomerular and tubular function following orthotopic liver transplantation in children treated with tacrolimus. Pediatr Transplant 2012; 16: 250-256.
26. Furth SL, Abraham AG, Jerry-Fluker J, et al,. Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2132-2140.
27. Collins AJ, Foley RN, Herzog C, et al,. Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis 2010; 55 (Suppl 1): S1-A7.
28. Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG,. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int 2000; 57: 1176-1181.
29. McDonald SP, Craig JC,. Long-term survival of children with end-stage renal disease. N Engl J Med 2004; 350: 2654-2662.
30. Wolfe RA, Ashby VB, Milford EL, et al,. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
31. Herlenius G, Felldin M, Norden G, et al,. Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: Results of a prospective randomized trial. Transplant Proc 2010; 42: 4441-4448.
32. Barkmann A, Nashan B, Schmidt HH, et al,. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil. Transplantation 2000; 69: 1886-1890.
33. Orlando G, Baiocchi L, Cardillo A, et al,. Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension. Liver Transplant 2007; 13: 46-54.
34. Sindhi R, Webber S, Venkataramanan R, et al,. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation 2001; 72: 851-855.
35. Appel LJ, Wright JT, Jr., Greene T, et al,. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010; 363: 918-929.
36. Wuhl E, Trivelli A, Picca S, et al,. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361: 1639-1650.
37. Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF,. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 2004; 19: 2852-2857.
38. Wright JT, Jr., Bakris G, Greene T, et al,. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 2002; 288: 2421-2431.
39. Patzer L,. Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 2008; 23: 2159-2173.
40. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB,. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations. Liver Transplant 2004; 10: 301-309.
41. Berding G, Geisler S, Melter M, et al,. Estimation of glomerular filtration rate in liver-transplanted children: Comparison of simplified procedures using 51Cr-EDTA and endogenous markers with Sapirstein's method as a reference standard. Pediatr Transplant 2010; 14: 786-795.
42. Borrows R, Cockwell P,. Measuring renal function in solid organ transplant recipients. Transplantation 2007; 83: 529-531.
43. Fadrowski JJ, Neu AM, Schwartz GJ, Furth SL,. Pediatric GFR estimating equations applied to adolescents in the general population. Clin J Am Soc Nephrol 2011; 6: 1427-1435.